Klingman & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.94M | Sell |
|
|||||
|
2025
Q2 | $2.42M | Buy |
|
|||||
|
2025
Q1 | $2.45M | Buy |
|
|||||
|
2024
Q4 | $1.99M | Sell |
|
|||||
|
2024
Q3 | $2.3M | Buy |
|
|||||
|
2024
Q2 | $1.47M | Buy |
|
|||||
|
2024
Q1 | $1.51M | Buy |
|
|||||
|
2023
Q4 | $1.28M | Buy |
|
|||||
|
2023
Q3 | $1.23M | Buy |
|
|||||
|
2023
Q2 | $1.1M | Buy |
|
|||||
|
2023
Q1 | $1.27M | Buy |
|
|||||
|
2022
Q4 | $1.28M | Buy |
|
|||||
|
2022
Q3 | $1.05M | Buy |
|
|||||
|
2022
Q2 | $1.2M | Sell |
|
|||||
|
2022
Q1 | $1.29M | Buy |
|
|||||
|
2021
Q4 | $688K | Buy |
|
|||||
|
2021
Q3 | $541K | Buy |
|
|||||
|
2021
Q2 | $558K | Buy |
|
|||||
|
2021
Q1 | $528K | Buy |
|
|||||
|
2020
Q4 | $517K | Hold |
|
|||||
|
2020
Q3 | $423K | Buy |
|
|||||
|
2020
Q2 | $372K | Hold |
|
|||||
|
2020
Q1 | $289K | Hold |
|
|||||
|
2019
Q4 | $336K | Hold |
|
|||||
|
2019
Q3 | $287K | Hold |
|
|||||
|
2019
Q2 | $276K | Hold |
|
|||||
|
2019
Q1 | $305K | Buy |
|
|||||
|
2018
Q4 | $340K | Hold |
|
|||||
|
2018
Q3 | $349K | Hold |
|
|||||
|
2018
Q2 | $341K | Sell |
|
|||||
|
2018
Q1 | $359K | Buy |
|
|||||
|
2017
Q4 | $356K | Hold |
|
|||||
|
2017
Q3 | $327K | Sell |
|
|||||
|
2017
Q2 | $314K | Buy |
|
|||||
|
2017
Q1 | $265K | Buy |
|
|||||
|
2016
Q4 | $253K | Hold |
|
|||||
|
2016
Q3 | $255K | Hold |
|
|||||
|
2016
Q2 | $250K | Hold |
|
|||||
|
2016
Q1 | $231K | Hold |
|
|||||
|
2015
Q4 | $239K | Buy |
|
|||||
|
2015
Q3 | $181K | Sell |
|
|||||
|
2015
Q2 | $236K | Buy |
|
|||||
|
2015
Q1 | $195K | Hold |
|
|||||
|
2014
Q4 | $218K | Buy |
|